Echevarría J M, León P, Balfagón P, López J A, Fernández M V
Centro Nacional de Microbiología, Virología e Immunología Sanitarias, Madrid, Spain.
Eur J Clin Microbiol Infect Dis. 1990 Mar;9(3):217-20. doi: 10.1007/BF01963842.
The performance of two new commercial assays for the serological diagnosis of Mycoplasma pneumoniae infection (microparticle agglutination and antibody-capture enzyme-immunoassay) was studied using a panel of 169 serum samples from patients with Mycoplasma pneumoniae pneumonia and a control group. Both assays were shown to be sensitive and specific for diagnosis. The performance of the capture immunoassay, however, decreased in older patients, probably due to its inability to detect cases of reinfection without IgM antibody response.
使用一组来自肺炎支原体肺炎患者的169份血清样本和一个对照组,研究了两种用于肺炎支原体感染血清学诊断的新型商业检测方法(微粒凝集法和抗体捕获酶免疫测定法)。两种检测方法均显示出对诊断具有敏感性和特异性。然而,捕获免疫测定法在老年患者中的性能有所下降,这可能是由于其无法检测到无IgM抗体反应的再感染病例。